4.6 Article

Structural Biology of Human H3K9 Methyltransferases

Journal

PLOS ONE
Volume 5, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0008570

Keywords

-

Funding

  1. Canadian Institutes for Health Research
  2. Canadian Foundation for Innovation
  3. Genome Canada through the Ontario Genomics Institute
  4. GlaxoSmithKline
  5. Karolinska Institutet
  6. Knut and Alice Wallenberg Foundation
  7. Ontario Innovation Trust
  8. Ontario Ministry for Research and Innovation
  9. Merck Co., Inc.
  10. Novartis Research Foundation
  11. Swedish Agency for Innovation Systems
  12. Swedish Foundation for Strategic Research
  13. Wellcome Trust

Ask authors/readers for more resources

SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available